GSK plc has exited the consumer health market with the spin-off of Haleon as a standalone business.
Following more than two years of planning, Haleon began trading on the London Stock Exchange on 18 July, closing the...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?